EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses

Benlin Wang, Yifeng Qiu, Ming Xie, Pengcheng Huang, Yao Yu, Qi Sun, Wentai Shangguan, Weijia Li, Zhangrui Zhu, Jingwen Xue, Zhengyuan Feng, Yuexuan Zhu und 2 weitere

BMC Microbiology · 03.07.2024 · 24 (1)

DOI: 10.1186/s12866-024-03372-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 03.07.2024. Verfasst von Benlin Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Gastrointestinal Microbiome, Immunotherapy, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Bladder cancer(BCa) was a disease that seriously affects patients’ quality of life and prognosis. To address this issue, many researches suggested that the gut microbiota modulated tumor response to treatment; however, this had not been well-characterized in bladder cancer. In this study, our objective was to determine whether the diversity and composition of the gut microbiota or the density of specific bacterial genera influence the prognosis of patients with bladder cancer.

Methods

We collected fecal samples from a total of 50 bladder cancer patients and 22 matched non-cancer individuals for 16S rDNA sequencing to investigate the distribution of Parabacteroides in these two groups. Further we conducted follow-up with cancer patients to access the impact of different genera of microorganisms on patients survival. We conducted a Fecal Microbiota Transplantation (FMT) and mono-colonization experiment with Parabacteroides distasonis to explore its potential enhancement of the efficacy of anti-PD-1 immunotherapy in MB49 tumor-bearing mice. Immunohistochemistry, transcriptomics and molecular experiment analyses were employed to uncover the underlying mechanisms.

Results

The 16S rDNA showed that abundance of the genus Parabacteroides was elevated in the non-cancer control group compared to bladder cancer group. The results of tumor growth curves showed that a combination therapy of P. distasonis and ICIs treatment significantly delayed tumor growth and increased the intratumoral densities of both CD4 + T and CD8 + T cells. The results of transcriptome analysis demonstrated that the pathways associated with antitumoral immune response were remarkably upregulated in the P. distasonis gavage group.

Conclusion

P. distasonis delivery combined with α-PD-1 mAb could be a new strategy to enhance the effect of anti-PD-1 immunotherapy. This effect might be achieved by activating immune and antitumor related pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsGastrointestinal MicrobiomeImmunotherapyFecal Microbiota TransplantationBacteroidetesAnimalsHumansMiceFemaleMaleRNA, Ribosomal, 16SFecesMiddle AgedAgedMice, Inbred C57BL

Stichwörter der Autor:innen

Parabacteroides distasonisBladder cancerGut microbiotaImmune checkpoint inhibitors

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. doctorwupeng@gmail.com.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province of China

Zitieren

APA

Wang, B., Qiu, Y., Xie, M., Huang, P., Yu, Y., Sun, Q., Shangguan, W., Li, W., Zhu, Z., Xue, J., Feng, Z., Zhu, Y., Yang, Q., & Wu, P. (2024). Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03372-8

Vancouver

Wang B, Qiu Y, Xie M, Huang P, Yu Y, Sun Q, et al. Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03372-8

BibTeX
@article{Wang2024,
  author = {Wang, Benlin and Qiu, Yifeng and Xie, Ming and Huang, Pengcheng and Yu, Yao and Sun, Qi and Shangguan, Wentai and Li, Weijia and Zhu, Zhangrui and Xue, Jingwen and Feng, Zhengyuan and Zhu, Yuexuan and Yang, Qishen and Wu, Peng},
  title = {Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses},
  journal = {BMC Microbiology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12866-024-03372-8}
}
Kostenlos starten →